The article published by Borsa Italiana highlights the strategic and social value of iSee glasses, recently registered as a Class 1 Medical Device. A significant milestone that creates new opportunities for accessibility and inclusion, while recognizing iVision Tech’s commitment to research and innovation for people with visual impairments.
